This hypothesis was supported by the CCR7 measurements that revealed a significant increase in the abundance of this receptor (a major actor in the DC migration to the lymphatics) on DCs exposed to PDT-killed mesothelioma cells Ab1 and Ab12 (vs. LPS-treated DC) (Figure 7C). The gene discussed is CCR7; the disease is mesothelioma.